Fieldpoint Private Securities’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1K Sell
10
-32
-76% -$2.58K ﹤0.01% 1310
2022
Q1
$4K Sell
42
-20
-32% -$1.88K ﹤0.01% 1320
2021
Q4
$6K Buy
62
+15
+32% +$1.53K ﹤0.01% 1211
2021
Q3
$5K Buy
47
+12
+34% +$1.21K ﹤0.01% 1252
2021
Q2
$4K Sell
35
-10
-22% -$1.02K ﹤0.01% 1248
2021
Q1
$4K Sell
45
-60
-57% -$5.55K ﹤0.01% 1239
2020
Q4
$10K Buy
+105
New +$9.24K ﹤0.01% 907

Other funds holding CRI

Fieldpoint Private Securities's CRI Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Carter's (CRI) stake by 76% in Q2 2022, selling an estimated $2.58K and leaving 10 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1310.

Fieldpoint Private Securities first reported a position in CRI in Q4 2020 and has held it in 7 quarters since. The position peaked at $10K in Q4 2020. 315 funds tracked by Wall St. Rank hold CRI as of Q2 2022.

  • Fieldpoint Private Securities held 10 shares of Carter's worth $1K as of Q2 2022.
  • Fieldpoint Private Securities sold 32 Carter's shares in Q2 2022, an estimated $2.58K.
  • Carter's made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1310 holding.
  • Fieldpoint Private Securities first reported a position in Carter's in Q4 2020 and has held it in 7 quarters since.
  • Fieldpoint Private Securities's Carter's position peaked at $10K in Q4 2020.
  • 315 funds tracked by Wall St. Rank held Carter's as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.